Literature DB >> 19715938

Oral ulcers during the course of cytomegalovirus infection in renal transplant recipients.

R M López-Pintor1, G Hernández, L de Arriba, J M Morales, C Jiménez, A de Andrés.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) infection is frequent in kidney transplant recipients. Although involvement of the gastrointestinal tract with CMV has been described, intra-oral localization is rare. The aim of this study was to analyze the incidence, clinical characteristics, treatment, and outcome of renal transplant recipients with oral lesions due to CMV. PATIENTS AND METHODS: We analyzed the records of 453 patients who underwent kidney transplantation between February 1989 and March 2007. Incident cases and characteristics of CMV oral lesions were ascertained retrospectively in the outpatient records.
RESULTS: The cumulative incidence of 6 cases with oral ulcerations was 1.32%. The median follow-up (n = 453) was 61.84 +/- 50.68 months. The interval for the incidence of CMV oral ulcers after renal transplantation was 12.83 +/- 23.51 months. The affected oral locations included the buccal mucosa, hard palate, soft palate, tongue, and floor of the mouth. CMV cases showed no significant difference with regard to gender distribution, age at renal transplantation, renal transplant indication, type of immunosuppressive treatment, and donor/recipient CMV serological status before transplantation. The number of acute rejection episodes was significantly greater and time since transplantation was significantly shorter in CMV cases.
CONCLUSION: CMV infection, which is common in renal transplant recipients, only rarely affects the mouth. Herein we have reported 6 patients who suffered oral ulcers due to CMV infection. An early diagnosis of these lesions is important to a successful outcome for these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715938     DOI: 10.1016/j.transproceed.2009.06.053

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Cytomegalovirus oral ulcers.

Authors:  T Ueda; Hideyuki Ogata; Yusuke Kojima; Eri Ishida
Journal:  Infection       Date:  2013-10-29       Impact factor: 3.553

2.  Oral shedding of human herpesviruses in renal transplant recipients.

Authors:  Dmitry José de Santana Sarmento; Tânia Regina Tozetto-Mendoza; Laura Masami Sumita; Ligia Camara Pierroti; Débora Pallos; Rubens Caliento; Michelle Palmieri; Victor Adriano de Oliveira Martins; Marina Gallottini; Claudio Sergio Pannuti; Paulo Henrique Braz-Silva
Journal:  Clin Oral Investig       Date:  2017-07-01       Impact factor: 3.573

3.  Rare oral lesions from cytomegalovirus in kidney transplant.

Authors:  Mohankumar Doraiswamy; Todd E Pesavento; Deepali Pandey; Raja Damayanthi Murali; Priyamvada Singh
Journal:  Postgrad Med J       Date:  2022-02       Impact factor: 2.401

Review 4.  Oral manifestations in transplant patients.

Authors:  Deepika Nappalli; Ashok Lingappa
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

5.  Human Cytomegalovirus Replication and Infection-Induced Syncytia Formation in Labial, Foreskin, and Fetal Lung Fibroblasts.

Authors:  Alexis Aguiar; Melissa Galinato; Maite' Bradley Silva; Bryant Toth; Michael A McVoy; Laura Hertel
Journal:  Viruses       Date:  2021-11-24       Impact factor: 5.048

6.  Oral candidiasis in patients with renal transplants.

Authors:  Rosa-María López-Pintor; Gonzalo Hernández; Lorenzo de Arriba; Amado de Andrés
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-05-01

7.  Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.

Authors:  Kwai-Fong Lee; Yi-Ting Tsai; Chih-Yuan Lin; Chung-Bao Hsieh; Sheng-Tang Wu; Hung-Yen Ke; Yi-Chang Lin; Feng-Yen Lin; Wei-Hwa Lee; Chien-Sung Tsai
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

8.  Rare oral lesions from cytomegalovirus in kidney transplant.

Authors:  Mohankumar Doraiswamy; Todd E Pesavento; Deepali Pandey; Raja Damayanthi Murali; Priyamvada Singh
Journal:  Postgrad Med J       Date:  2021-06-30       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.